Snapshot

The Conditional Marketing Authorization pathway has been developed by the of Cuba.

This pathway can be used where pharmaceutical products for human use.

This pathway accelerates the regulatory review process.

It is an abridged review (a reliance pathway).

Marketing authorization: 180 calendar days. Variations: 150 calendar days. Renewals: 150 calendar days.